First Time Loading...

IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 230.19 USD 0.92%
Updated: Apr 22, 2024

Intrinsic Value

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. [ Read More ]

The intrinsic value of one IQV stock under the Base Case scenario is 265.58 USD. Compared to the current market price of 230.19 USD, IQVIA Holdings Inc is Undervalued by 13%.

Key Points:
IQV Intrinsic Value
Base Case
265.58 USD
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IQVIA Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IQV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
IQVIA Holdings Inc

Provide an overview of the primary business activities
of IQVIA Holdings Inc.

What unique competitive advantages
does IQVIA Holdings Inc hold over its rivals?

What risks and challenges
does IQVIA Holdings Inc face in the near future?

Has there been any significant insider trading activity
in IQVIA Holdings Inc recently?

Summarize the latest earnings call
of IQVIA Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IQVIA Holdings Inc.

Provide P/S
for IQVIA Holdings Inc.

Provide P/E
for IQVIA Holdings Inc.

Provide P/OCF
for IQVIA Holdings Inc.

Provide P/FCFE
for IQVIA Holdings Inc.

Provide P/B
for IQVIA Holdings Inc.

Provide EV/S
for IQVIA Holdings Inc.

Provide EV/GP
for IQVIA Holdings Inc.

Provide EV/EBITDA
for IQVIA Holdings Inc.

Provide EV/EBIT
for IQVIA Holdings Inc.

Provide EV/OCF
for IQVIA Holdings Inc.

Provide EV/FCFF
for IQVIA Holdings Inc.

Provide EV/IC
for IQVIA Holdings Inc.

Show me price targets
for IQVIA Holdings Inc made by professional analysts.

What are the Revenue projections
for IQVIA Holdings Inc?

How accurate were the past Revenue estimates
for IQVIA Holdings Inc?

What are the Net Income projections
for IQVIA Holdings Inc?

How accurate were the past Net Income estimates
for IQVIA Holdings Inc?

What are the EPS projections
for IQVIA Holdings Inc?

How accurate were the past EPS estimates
for IQVIA Holdings Inc?

What are the EBIT projections
for IQVIA Holdings Inc?

How accurate were the past EBIT estimates
for IQVIA Holdings Inc?

Compare the revenue forecasts
for IQVIA Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IQVIA Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IQVIA Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of IQVIA Holdings Inc compared to its peers.

Compare the P/E ratios
of IQVIA Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing IQVIA Holdings Inc with its peers.

Analyze the financial leverage
of IQVIA Holdings Inc compared to its main competitors.

Show all profitability ratios
for IQVIA Holdings Inc.

Provide ROE
for IQVIA Holdings Inc.

Provide ROA
for IQVIA Holdings Inc.

Provide ROIC
for IQVIA Holdings Inc.

Provide ROCE
for IQVIA Holdings Inc.

Provide Gross Margin
for IQVIA Holdings Inc.

Provide Operating Margin
for IQVIA Holdings Inc.

Provide Net Margin
for IQVIA Holdings Inc.

Provide FCF Margin
for IQVIA Holdings Inc.

Show all solvency ratios
for IQVIA Holdings Inc.

Provide D/E Ratio
for IQVIA Holdings Inc.

Provide D/A Ratio
for IQVIA Holdings Inc.

Provide Interest Coverage Ratio
for IQVIA Holdings Inc.

Provide Altman Z-Score Ratio
for IQVIA Holdings Inc.

Provide Quick Ratio
for IQVIA Holdings Inc.

Provide Current Ratio
for IQVIA Holdings Inc.

Provide Cash Ratio
for IQVIA Holdings Inc.

What is the historical Revenue growth
over the last 5 years for IQVIA Holdings Inc?

What is the historical Net Income growth
over the last 5 years for IQVIA Holdings Inc?

What is the current Free Cash Flow
of IQVIA Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for IQVIA Holdings Inc.

Financials

Balance Sheet Decomposition
IQVIA Holdings Inc

Current Assets 5.6B
Cash & Short-Term Investments 1.5B
Receivables 3.4B
Other Current Assets 687m
Non-Current Assets 21.1B
Long-Term Investments 239m
PP&E 819m
Intangibles 19.4B
Other Non-Current Assets 621m
Current Liabilities 6.5B
Accounts Payable 3.6B
Other Current Liabilities 2.9B
Non-Current Liabilities 14.1B
Long-Term Debt 13B
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
IQVIA Holdings Inc

Revenue
15B USD
Cost of Revenue
-9.7B USD
Gross Profit
5.2B USD
Operating Expenses
-3.2B USD
Operating Income
2.1B USD
Other Expenses
-703m USD
Net Income
1.4B USD

Free Cash Flow Analysis
IQVIA Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

IQV Profitability Score
Profitability Due Diligence

IQVIA Holdings Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
ROE is Increasing
Positive 3-Year Average ROE
58/100
Profitability
Score

IQVIA Holdings Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

IQV Solvency Score
Solvency Due Diligence

IQVIA Holdings Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
High D/E
32/100
Solvency
Score

IQVIA Holdings Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IQV Price Targets Summary
IQVIA Holdings Inc

Wall Street analysts forecast IQV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IQV is 281.34 USD with a low forecast of 237.35 USD and a high forecast of 315 USD.

Lowest
Price Target
237.35 USD
3% Upside
Average
Price Target
281.34 USD
22% Upside
Highest
Price Target
315 USD
37% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

IQV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IQV Price
IQVIA Holdings Inc

1M 1M
-9%
6M 6M
+25%
1Y 1Y
+13%
3Y 3Y
+2%
5Y 5Y
+71%
10Y 10Y
+361%
Annual Price Range
230.19
52w Low
177.16
52w High
259.1
Price Metrics
Average Annual Return 14.69%
Standard Deviation of Annual Returns 32.85%
Max Drawdown -49%
Shares Statistics
Market Capitalization 41.8B USD
Shares Outstanding 182 014 000
Percentage of Shares Shorted 1.82%

IQV Return Decomposition
Main factors of price return

What is price return decomposition?

IQV News

Other Videos

Company Profile

IQVIA Holdings Inc Logo
IQVIA Holdings Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

41.8B USD

Dividend Yield

0%

Description

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 79,000 full-time employees. The company went IPO on 2013-05-09. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.

Contact

NORTH CAROLINA
Durham
4820 Emperor Blvd
+19199982000.0
https://ir.iqvia.com/

IPO

2013-05-09

Employees

79 000

Officers

CEO & Chairman
Mr. Ari Bousbib
Executive VP & CFO
Mr. Ronald E. Bruehlman
Executive VP, General Counsel & Secretary
Mr. Eric M. Sherbet
President of Research & Development Solutions
Mr. W. Richard Staub III
President of Corporate Strategy & Enterprise Networks
Mr. Kevin C. Knightly
Senior VP, Corporate Controller & Chief Accounting Officer
Ms. Keriann Cherofsky
Show More
Executive Vice President of Global Technology & Operations
Mr. Jim Berkshire
Senior VP, Global Chief Medical & Scientific Officer
Dr. Jeffrey A. Spaeder M.D.
SVP of Investment Relation & Treasury
Kerri Joseph
Chief Human Resources Officer & Executive VP
Ms. Trudy Stein
Show Less

See Also

Discover More
What is the Intrinsic Value of one IQV stock?

The intrinsic value of one IQV stock under the Base Case scenario is 265.58 USD.

Is IQV stock undervalued or overvalued?

Compared to the current market price of 230.19 USD, IQVIA Holdings Inc is Undervalued by 13%.